While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

Trump said he plans to escalate the tariff rate to 150 per cent and eventually to 250 per cent within a year to a year and a ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Thursday before the bell. Here’s what ...

Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...

A contract company for a fiber optics provider has hit a water line, forcing Lilly Grove Water Supply to issue a boil-water ...

The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva Pharma, to help ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

Eli Lilly's stock is lagging the S&P 500 since April, potentially allowing a catch-up trade if results impress. Medicare may ...

Lawsuits from at least 26 patients have been filed in Marion County against Eli Lilly and Co. for its marketing of the drugs ...

The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

The amount of credits the company receives is contingent upon its meeting job creation and capital investment goals.

Novo Nordisk stock was downgraded to Neutral from Buy by UBS analysts, who cited the threat posed by Eli Lilly as just one ...